A new research survey of 500 biopharma executives, commissioned by TetraScience and AWS, reveals why life sciences companies need to rethink their data platforms. Replatforming scientific data to an open cloud platform while transforming the data to FAIR (Findable, Accessible, Interoperable, Reusable) principles significantly impacts three key industry drivers:
o Speed: Learning from experiments faster, reducing time to market for final molecules.
o Cost: Improving productivity, increasing operational efficiency, increasing return on investment (ROI).
o Risk: Improving safety, reducing errors, improving compliance with regulatory requirements.
The speakers will also share insights and updates from the Bio-IT World Conference. Whether you’re just getting started or are developing the next phases of your replatforming strategy, this webinar will provide you with essential information and key insights.
● Competitive advantages to developing a scientific data cloud strategy
● Best approaches to getting started with replatformed scientific data in the cloud
● Long-term advantages, including moving into ML, AI, and advanced analytics
Chad Garrett, Chief Revenue Officer, TetraScience
Himanshu Jain, Healthcare and Life Sciences Industry Strategy Leader, Amazon Web Services (AWS)